APA citiranje

Uzawa, A., Mori, M., Masuda, H., Ohtani, R., Uchida, T., & Kuwabara, S. (2018). Recombinant thrombomodulin ameliorates experimental autoimmune encephalomyelitis by suppressing high mobility group box 1 and inflammatory cytokines. Clin Exp Immunol.

Citação norma Chicago

Uzawa, A., M. Mori, H. Masuda, R. Ohtani, T. Uchida, and S. Kuwabara. "Recombinant Thrombomodulin Ameliorates Experimental Autoimmune Encephalomyelitis By Suppressing High Mobility Group Box 1 and Inflammatory Cytokines." Clin Exp Immunol 2018.

MLA citiranje

Uzawa, A., et al. "Recombinant Thrombomodulin Ameliorates Experimental Autoimmune Encephalomyelitis By Suppressing High Mobility Group Box 1 and Inflammatory Cytokines." Clin Exp Immunol 2018.